RECRO Pharma
Malvern, US · Pennsylvania corporation · 1 known investors
Specialty biopharmaceutical company developing differentiated prescription drugs for analgesia, anesthesia, sedation, and chronic pain management.
Biotech
Founders & leadership
GA
Gerri A. HenwoodExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$16MraisedJul 2015 · 3 investors · PharmaceuticalsRule 506(b)
▶$16MraisedJul 2015 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gerri A HenwoodExecutive Officer, Director
- Winston J ChurchillDirector
- William L AshtonDirector
- Abraham LudomirskiDirector
- Alfred AltomariDirector
- Michael BerelowitzDirector
- Donna NicholsExecutive Officer
- Charles GarnerExecutive Officer
- Wayne B WeismanDirector
- Offering amount
- $16M
- Amount sold
- $16M
- Sales commissions
- $960K
- Placement agents
- MLV & Co. LLC, Janney Montgomery Scott LLC, Jefferies LLC, Brean Capital, LLC
- First sale
- Jul 2015
- Incorporated
- Corporation, Pennsylvania
- Federal exemptions
- 06b
▶$7.8MraisedApr 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$7.8MraisedApr 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gerri A. HenwoodExecutive Officer
- Offering amount
- $7.8M
- Amount sold
- $7.8M
- First sale
- Apr 2015
- Incorporated
- Corporation, Pennsylvania
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.